AIM: Cardiovascular disease (CV) is the second leading cause of morbidity and mortality in chronic obstructive pulmonary disease (COPD). Peripheral arterial disease (PAD) is associated with cardiovascular disease, and its risk factors are common to other atherosclerotic diseases. The objective is to determine the prevalence of PAD in a population of patients with COPD using the ankle / brachial index (ABI) and to investigate the relationship between PAD and lung disease severity. METHODS: In a prospective cross-sectional study, 246 patients with COPD were recruited. Patients were enrolled consecutively according to their admission to Povisa hospital from September 1, 2008, until March 1, 2010, and were assessed by clinical history, spirometry and ABI. The COPD severity was graded by GOLD criteria in spirometry. RESULTS: Overall, 84 patients (36.8%) had abnormal ABI results and 59 (70.2%) were asymptomatic for PAD. COPD patients with PAD had a higher prevalence of moderate to severe COPD (61.9% vs. 41.7%, P=0.004), lower mean forced expiratory volume in 1 second (FEV1) values (46.7% ± 15 vs. 52.3±14%, P=0.001) and a higher prevalence of hypertension (69% vs. 54.3%, P=0.03) and previous cardiovascular disease (34.5% vs. 21.3%, P=0.03). CONCLUSION: There was a high prevalence of asymptomatic PAD in the COPD patients we examined. Abnormal ABI results were associated with a higher prevalence of cardiovascular risk factors and more severe lung disease. The diagnosis of peripheral arterial disease in COPD is important because this is an entity that limits the patient's physical activity and impairs their quality of life in addition to turn it into a high cardiovascular risk patient that requiring additional therapeutic measures.
AIM: Cardiovascular disease (CV) is the second leading cause of morbidity and mortality in chronic obstructive pulmonary disease (COPD). Peripheral arterial disease (PAD) is associated with cardiovascular disease, and its risk factors are common to other atherosclerotic diseases. The objective is to determine the prevalence of PAD in a population of patients with COPD using the ankle / brachial index (ABI) and to investigate the relationship between PAD and lung disease severity. METHODS: In a prospective cross-sectional study, 246 patients with COPD were recruited. Patients were enrolled consecutively according to their admission to Povisa hospital from September 1, 2008, until March 1, 2010, and were assessed by clinical history, spirometry and ABI. The COPD severity was graded by GOLD criteria in spirometry. RESULTS: Overall, 84 patients (36.8%) had abnormal ABI results and 59 (70.2%) were asymptomatic for PAD. COPDpatients with PAD had a higher prevalence of moderate to severe COPD (61.9% vs. 41.7%, P=0.004), lower mean forced expiratory volume in 1 second (FEV1) values (46.7% ± 15 vs. 52.3±14%, P=0.001) and a higher prevalence of hypertension (69% vs. 54.3%, P=0.03) and previous cardiovascular disease (34.5% vs. 21.3%, P=0.03). CONCLUSION: There was a high prevalence of asymptomatic PAD in the COPDpatients we examined. Abnormal ABI results were associated with a higher prevalence of cardiovascular risk factors and more severe lung disease. The diagnosis of peripheral arterial disease in COPD is important because this is an entity that limits the patient's physical activity and impairs their quality of life in addition to turn it into a high cardiovascular risk patient that requiring additional therapeutic measures.
Authors: Miguel J Divo; Carlos Cabrera; Ciro Casanova; Jose M Marin; Victor M Pinto-Plata; Juan P de-Torres; Javier Zulueta; Jorge Zagaceta; Pablo Sanchez-Salcedo; Juan Berto; Claudia Cote; Bartolome R Celli Journal: Chronic Obstr Pulm Dis Date: 2014-09-25
Authors: Divay Chandra; Aman Gupta; Patrick J Strollo; Carl R Fuhrman; Joseph K Leader; Jessica Bon; William A Slivka; Ali Hakim Shoushtari; Jennifer Avolio; Kevin E Kip; Steven Reis; Frank C Sciurba Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405
Authors: Carlos A Vaz Fragoso; Fang-Chi Hsu; Tina Brinkley; Timothy Church; Christine K Liu; Todd Manini; Anne B Newman; Randall S Stafford; Mary M McDermott; Thomas M Gill Journal: J Am Med Dir Assoc Date: 2014-06-25 Impact factor: 4.669
Authors: Ula Chetty; Gary McLean; Deborah Morrison; Karolina Agur; Bruce Guthrie; Stewart W Mercer Journal: Br J Gen Pract Date: 2017-05 Impact factor: 5.386
Authors: Kannayiram Alagiakrishnan; Michael Brokop; Andrew Cave; Brian H Rowe; Eric Wong; Ambikaipakan Senthilselvan Journal: J Clin Med Res Date: 2016-02-27
Authors: Carmen Pizarro; Fabian Linnhoff; Fabian van Essen; Simon Pingel; Christian Alexander Schaefer; Nadjib Schahab; Rolf Fimmers; Georg Nickenig; Dirk Skowasch Journal: ERJ Open Res Date: 2016-10-26
Authors: Loes C M Bertens; Johannes B Reitsma; Karel G M Moons; Yvonne van Mourik; Jan Willem J Lammers; Berna D L Broekhuizen; Arno W Hoes; Frans H Rutten Journal: Int J Chron Obstruct Pulmon Dis Date: 2013-10-10